The Future of Probiotics (Part Two): Chronic Disease and Science Versus Regulation
Chronic diseases are going to create a new leverage point for probiotic products, especially in the area of cardiovascular health and diabetes. Part two of this global briefing on probiotics aims to highlight where future growth in probiotics is to be found. It also reviews the regulatory status and shows how both permitting and banning health claims can have a strong impact on the marketplace.
Euromonitor International's The Future of Probiotics (Part Two): Chronic Disease and Science Versus Regulation global briefing offers an insight into to the size and shape of the health and wellness marketplace, highlights buzz topics, emerging trends, categories and geographies as well as pressing industry issues and white spaces. It identifies the leading companies and brands, offers strategic analysis of key factors influencing wellbeing market - be they new product developments, packaging and ingredients innovations, introduction of new regulatory schemes, economic/lifestyle influences, distribution or retail pricing issues. Forecasts illustrate how the market is set to change and criteria for success.
Product coverage: Health and Wellness by Category, Health and Wellness by Prime Positioning, Health and Wellness by Type.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook